Given that SQLE is overexpressed in pancreatic cancer and plays a role in tumor progression through cholesterol metabolism, targeting this enzyme with HCJ007 could lead to reduced tumor growth and improved patient outcomes. The gene discussed is SQLE; the disease is familial pancreatic carcinoma.